Phase I study of TTC-352 in patients with estrogen receptor-positive metastatic breast cancer

被引：1
|
作者：
ORegan, Ruth M. [1 ]
Hurley, Randolph [2 ]
Sachdev, Jasgit C. [3 ]
Bleeker, Jonathan [4 ]
Tonetti, Debra [5 ]
Thatcher, Gregory [5 ]
Venuti, Robert [5 ]
Dudek, Arkadiusz Z. [5 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] HealthPartners Reg Canc Care Ctr, Minneapolis, MN USA
[3] HonorHlth Res Inst TGen, Scottsdale, AZ USA
[4] Sanford Hlth, Sioux Falls, SD USA
[5] TTC Oncol, Minneapolis, MN USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-CT051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT051
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine therapy
    O'Regan, Ruth
    Hurley, Randolph
    Sachdev, Jasgit
    Bleeker, Jonathan
    Tonetti, Debra
    Thatcher, Gregory
    Venuti, Robert
    Dudek, Arkadiusz
    CANCER RESEARCH, 2020, 80 (04)
  • [2] Study TTC-352-101: Phase 1 study of TTC-352 in patients with metastatic breast cancer (BC) progressing on endocrine therapy.
    O'Regan, Ruth
    Hurley, Randolph
    Sachdev, Jasgit C.
    Tonetti, Debra A.
    Thatcher, Gregory R.
    Venuti, Robert P.
    Dudek, Arkadiusz Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy
    Arkadiusz Z. Dudek
    Li C. Liu
    James H. Fischer
    Elizabeth L. Wiley
    Jasgit C. Sachdev
    Jonathan Bleeker
    Randolph W. Hurley
    Debra A. Tonetti
    Gregory R. J. Thatcher
    Robert P. Venuti
    Ruth M. O’Regan
    Breast Cancer Research and Treatment, 2020, 183 : 617 - 627
  • [4] Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy
    Dudek, Arkadiusz Z.
    Liu, Li C.
    Fischer, James H.
    Wiley, Elizabeth L.
    Sachdev, Jasgit C.
    Bleeker, Jonathan
    Hurley, Randolph W.
    Tonetti, Debra A.
    Thatcher, Gregory R. J.
    Venuti, Robert P.
    O'Regan, Ruth M.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (03) : 617 - 627
  • [5] Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
    Gucalp, Ayca
    Tolaney, Sara
    Isakoff, Steven J.
    Ingle, James N.
    Liu, Minetta C.
    Carey, Lisa A.
    Blackwell, Kimberly
    Rugo, Hope
    Nabell, Lisle
    Forero, Andres
    Stearns, Vered
    Doane, Ashley S.
    Danso, Michael
    Moynahan, Mary Ellen
    Momen, Lamia F.
    Gonzalez, Joseph M.
    Akhtar, Arooj
    Giri, Dilip D.
    Patil, Sujata
    Feigin, Kimberly N.
    Hudis, Clifford A.
    Traina, Tiffany A.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5505 - 5512
  • [6] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 249 - 252
  • [7] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    ANNALS OF ONCOLOGY, 2017, 28 : 27 - 27
  • [8] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Hirotaka Iwase
    International Journal of Clinical Oncology, 2015, 20 : 249 - 252
  • [9] Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer
    Goldberg, Jonathan
    Qiao, Na
    Guerriero, Jennifer L.
    Gross, Brett
    Meneksedag, Yagiz
    Lu, Yoshimi F.
    Philips, Anne V.
    Rahman, Tasnim
    Meric-Bernstam, Funda
    Roszik, Jason
    Chen, Ken
    Jeselsohn, Rinath
    Tolaney, Sara M.
    Peoples, George E.
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 496 - 504
  • [10] Phase I study combining pembrolizumab and aromatase inhibitor in patients with metastatic hormone receptor-positive breast cancer.
    Ge, Xuan
    Yost, Susan Elaine
    Lee, Jin Sun
    Frankel, Paul Henry
    Ruel, Christopher
    Cui, Yujie
    Murga, Mireya
    Tang, Aileen
    Martinez, Norma
    Chung, Samuel
    Yeon, Christina Haeyoung
    Stewart, Daphne B.
    Li, Daneng
    Rajurkar, Swapnil Padmakar
    Somlo, George
    Mortimer, Joanne E.
    Waisman, James Ross
    Yuan, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345